Department of Health – Abu Dhabi launches Newborn Genetic Screening Programme
ABU DHABI (ALETIHAD)The Department of Health - Abu Dhabi (DoH), in alignment with the Emirati Genome Council's vision to realise a national shift towards personalised, precision healthcare, has launched the Newborn Genetic Screening Programme. The initiative translates Abu Dhabi's commitment to pioneering genomics-driven medicine that enables early detection and diagnosis, tailored interventions, and improved health outcomes for future generations.The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, making it one of the most comprehensive genetic screening programmes for newborns worldwide.Leveraging the power of genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE Nationals and children of Emirati mothers born in the emirate, further strengthening Abu Dhabi's leadership in preventive healthcare and precision medicine.By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. The conditions screened under the programme include metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which is treatable by gene therapy.Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before.She added: 'This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care, and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare.'Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.'To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi.DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening.Additionally, comprehensive workshops were conducted for obstetricians, midwives, nurses and technical teams from these facilities.Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified.Early detection through this enhanced screening programme allows for timely medical intervention and aligns with Abu Dhabi's broader strategy to integrate genomics into various aspects of family health, including premarital screening and genetic counselling, thus creating a comprehensive, family-centred care ecosystem. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard.
The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and the latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and well-being of future generations of Emiratis.
Source: Aletihad - Abu Dhabi
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 hours ago
- Zawya
Response Plus Medical, Austability sign strategic partner non-financial MoU
Abu Dhabi: Response Plus Medical Services LLC (RPM), a subsidiary of Response Plus Holding PJSC – the largest pre-hospital care and emergency medical services provider in the region, has signed a strategic partner non-financial Memorandum of Understanding (MoU) with Austability Group Ltd, delivering world class expeditionary integrated base operational support services across the globe. As part of the MoU, RPM, through its subsidiary Prometheus Medical International, will collaborate with Austability to extend services and capabilities to agencies, particularly in the international defence and national security sectors. The MoU is a strategic alliance to deliver operational support and pre-hospital, emergency care services. Dr Rohil Raghavan, CEO of Response Plus Holding PJSC, said: 'In line with our commitment to grow our presence and leadership in high-end medical and non-medical training, particularly in the defence sector, we are thrilled to enter into a strategic MoU with Austability, which will help RPM and Prometheus to strengthen their market access across geographies and defence establishments.' David Khandan, President and CEO of Austability said: 'Austability's established global operational footprint enables us to deliver agile, high-quality solutions to our clients. As a defence and national security industry leader, we are committed to providing specialized support services in complex and austere environments. By leveraging our deep industry experience, capability and global presence, this MoU with RPM will strengthen our ability to support our clients as part of our mission to foster peace and security around the world.' RPM currently operates over 420 medical sites through key subsidiaries including Prometheus Medical, Occumed Clinic, Health Tech Training Centre, and Medical Manpower Supply. With operations spanning the UAE, KSA, Oman, India, the UK, Switzerland, and Norway, RPM remains firmly committed to redefining the future of pre-hospital emergency medical services. Incorporated in 2015, Austability operates in 24 countries, with 13 offices worldwide. Austability's service provision framework offers innovative and expeditionary strategies to Defence and National Security agencies of the Five Eyes alliance (Australia, Canada, New Zealand, United Kingdom, and United States) and their allies and partners.
The National
2 hours ago
- The National
Abu Dhabi genetic screening drive to detect more than 800 conditions and boost health of UAE's next generation
A genetic screening programme for Emirati newborns has been launched in Abu Dhabi, with the move aimed at improving the chances of detecting conditions that could affect future quality of life. The Newborn Genetic Screening Programme, launched by the Department of Health in Abu Dhabi, along with the Emirati Genome Council, will place an increased emphasis on genomics -driven personalised care. With the consent of parents, cord blood samples will be collected and tested at birth. The results will then used to identify conditions that might not be apparent at birth but could affect a child's health if treatment is delayed. The screening aims to identify conditions including metabolic disorders, immunodeficiencies and hematologic conditions, as well as rare diseases such as spinal muscular atrophy, which can be treated with gene therapy. 'Health care begins long before symptoms appear and today, empowered by science and technology, we can act earlier than ever before," said Dr Noura Al Ghaithi, Undersecretary of the Department of Health in Abu Dhabi. 'This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision health care.' The department said the programme can screen for 815 treatable childhood genetic conditions. The first phase of the project is under way as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with technology-enabled healthcare company M42. The initiative is expected to be expanded across all maternity hospitals in Abu Dhabi to screen children of Emiratis. Working together The department has also collaborated with M42 to give paediatricians and neonatologists at Corniche Hospital, Danat Al Emarat and Kanad Hospital training on genetic counselling practices and the importance of newborn genetic screening. 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape health care, shifting from a one-size-fits-all model to a precise, proactive and personalised approach that improves patient outcomes," said Dr Mohamed Al Ameri, acting director of genome and biobank division at the Department of Health.
Dubai Eye
2 hours ago
- Dubai Eye
Abu Dhabi launches newborn genetic testing programme
Abu Dhabi has rolled out a newborn genetic screening programme for Emirati nationals across several hospitals, to enable early detection and diagnosis of genetic conditions. The Newborn Genetic Screening Programme offers whole genome sequencing to screen more than 815 treatable childhood genetic conditions, including metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy. Using genomics and artificial intelligence (AI), the first phase of the programme has been implemented as a voluntary option at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42. The initiative is planned to be expanded across all maternity hospitals to screen UAE nationals and children of Emirati mothers born in the emirate. By collecting and testing cord blood samples at birth, with parental consent, healthcare providers can identify conditions that may not be apparent at birth but could significantly affect a child's health if treatment is delayed. Results are reported within 21 days, and parents will receive genetic counselling and be referred to multidisciplinary specialists if any actionable findings are identified. 'Through early detection, personalised care and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare," said Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi. To support the rollout of the programme, DoH conducted a workshop to review the gene panel and patient journey with specialists from stakeholders across Abu Dhabi. DoH also collaborated with M42 to train 16 paediatricians and neonatologists across three maternity hospitals, Corniche Hospital, Danat Al Emarat and Kanad Hospital, on genetic counselling practices and the importance of newborn genetic screening. These initiatives aim to reduce the prevalence of genetic diseases, inform reproductive choices, facilitate access to early intervention, and empower families with vital health information, fostering a future where personalised, preventative healthcare is the standard. The Newborn Genetic Screening Programme is one of several initiatives that have been made possible by the Emirati Genome Programme, such as the Premarital Screening Programme, harnessing the power of genomics and latest technologies to promote informed decisions. These efforts pave the way forward for more precise and effective treatments, ensuring the long-term health and wellbeing of future generations of Emiratis.
